Importantly, our results indicate that NCoR and TRβ not only silence the expression of CXCR4 receptors in the breast tumor cells, but also reduce the production of its ligand, CXCL12, by the tumor environment. This evidence concerns the gene CXCL12 and breast neoplasm.